Fulgent Genetics (FLGT) Equity Income (2016 - 2019)

Fulgent Genetics has reported Equity Income for 4 years, with the latest figure at -$687000.0 in Q4 2019.

• Quarterly Equity Income rose 11.24% year-over-year to -$687000.0 in Q4 2019, while the trailing twelve-month figure through Dec 2019 was -$3.0 million (down 7.28% YoY) and the FY2019 annual result came in at -$3.0 million, up 2.97% from the prior year.
• Equity Income climbed to -$687000.0 in Q4 2019 per FLGT's latest filing, from -$899000.0 in the prior quarter.
• Over five years, Equity Income peaked at $7000.0 in Q4 2016 and troughed at -$899000.0 in Q3 2019.
• A 4-year average of -$628625.0 and a median of -$688500.0 in 2018 frame the typical range for Equity Income.
• The sharpest annual moves came in 2017 and 2019: Equity Income plunged 11785.71% in 2017, then climbed 11.24% in 2019.
• Over 4 years, Equity Income stood at $7000.0 in 2016, then slumped by 11785.71% to -$818000.0 in 2017, then advanced by 5.38% to -$774000.0 in 2018, then climbed by 11.24% to -$687000.0 in 2019.
• According to Business Quant data, Equity Income over the past three periods registered -$687000.0, -$899000.0, and -$774000.0 for Q4 2019, Q3 2019, and Q4 2018 respectively.